Income Statement
LUCID DIAGNOSTICS INC.
LUCD
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | 4.35 | 2.43 | - | 0.50 |
|
Cost of Revenue
|
6.67 | - | - | - | 0.59 |
|
Gross Profit
|
-6.67 | 4.35 | 2.43 | 0.38 | -0.09 |
|
Operating Expenses
|
29.55 | 50.40 | 50.91 | 56.55 | 27.33 |
|
Research & Development
|
5.68 | 5.99 | 7.25 | 11.47 | 9.30 |
|
Selling, General & Administrative
|
23.87 | 20.16 | 19.25 | 23.69 | 12.78 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-36.22 | -46.05 | -48.48 | -56.17 | -27.42 |
|
Non-Operating Income
|
-8.37 | -0.52 | 4.18 | 0.00 | 0.66 |
|
Interest Income
|
0.39 | 0.32 | 0.42 | - | - |
|
Interest Expense
|
- | 0.03 | 0.42 | - | 0.66 |
|
Other Non-Op Income / Expense
|
- | 0.52 | -4.18 | - | - |
|
Income Before Tax
|
-58.01 | -45.53 | -52.67 | -56.17 | -28.08 |
|
Income Tax Expense
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-58.01 | -45.53 | -52.67 | -56.17 | -28.08 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-35.34 | -44.89 | -45.98 | -54.24 | -27.42 |
|
Earnings Per Share (Basic)
|
-0.69 | -1.05 | -1.26 | -1.55 | - |
|
Diluted EPS
|
- | -1.05 | -1.26 | - | - |
|
Weighted Average Shares
|
101.95 | 50.52 | 41.76 | 36.17 | - |
|
Diluted Weighted Avg Shares
|
- | 50.52 | 41.76 | - | - |
|
Comprehensive Income
|
- | - | - | - | - |